Toll-like receptor 5-mediated signaling enhances liver regeneration in mice

• Published in: Military medical research 2021-02, Vol.8 (1), p.16-12, Article 16
• Main Authors: Zhang, Wen, Wang, Lei, Sun, Xue-Hua, Liu, Xian, Xiao, Yang, Zhang, Jie, Wang, Ting, Chen, Hui, Zhan, Yi-Qun, Yu, Miao, Ge, Chang-Hui, Li, Chang-Yan, Ren, Guang-Ming, Yin, Rong-Hua, Yang, Xiao-Ming
• Format: Article
• Language: English
• Subjects: Age; Animals; Antibodies; CBLB502; Cell cycle; Cytokines; Disease Models, Animal; Gene expression; Genetic engineering; Growth factors; Laboratory animals; Laparotomy; Lipids; Liver; Liver regeneration; Liver Regeneration - drug effects; Liver Regeneration - physiology; Mice; Mice, Inbred C57BL; NF-κB; Partial hepatectomy; Pathogens; Proteins; Signal Transduction - drug effects; Statistics, Nonparametric; Toll-like receptor 5; Toll-Like Receptor 5 - metabolism; Toll-Like Receptor 5 - therapeutic use
• ISSN: 2054-9369; 2095-7467; 2054-9369
• DOI: 10.1186/s40779-021-00309-4

Toll-like receptor 5 (TLR5)-mediated pathways play critical roles in regulating the hepatic immune response and show hepatoprotective effects in mouse models of hepatic diseases. However, the role of TLR5 in experimental models of liver regeneration has not been reported. This study aimed to investigate the role of TLR5 in partial hepatectomy (PHx)-induced liver regeneration. We performed 2/3 PHx in wild-type (WT) mice, TLR5 knockout mice, or TLR5 agonist CBLB502 treated mice, as a model of liver regeneration. Bacterial flagellin content was measured with ELISA, and hepatic TLR5 expression was determined with quantitative PCR analyses and flow cytometry. To study the effects of TLR5 on hepatocyte proliferation, we analyzed bromodeoxyuridine (BrdU) incorporation and proliferating cell nuclear antigen (PCNA) expression with immunohistochemistry (IHC) staining. The effects of TLR5 during the priming phase of liver regeneration were examined with quantitative PCR analyses of immediate early gene mRNA levels, and with Western blotting analysis of hepatic NF-κB and STAT3 activation. Cytokine and growth factor production after PHx were detected with real-time PCR and cytometric bead array (CBA) assays. Oil Red O staining and hepatic lipid concentrations were analyzed to examine the effect of TLR5 on hepatic lipid accumulation after PHx. The bacterial flagellin content in the serum and liver increased, and the hepatic TLR5 expression was significantly up-regulated in WT mice after PHx. TLR5-deficient mice exhibited diminished numbers of BrdU- and PCNA-positive cells, suppressed immediate early gene expression, and decreased cytokine and growth factor production. Moreover, PHx-induced hepatic NF-κB and STAT3 activation was inhibited in Tlr5 mice, as compared with WT mice. Consistently, the administration of CBLB502 significantly promoted PHx-mediated hepatocyte proliferation, which was correlated with enhanced production of proinflammatory cytokines and the recruitment of macrophages and neutrophils in the liver. Furthermore, Tlr5 mice displayed significantly lower hepatic lipid concentrations and smaller Oil Red O positive areas than those in control mice after PHx. We reveal that TLR5 activation contributes to the initial events of liver regeneration after PHx. Our findings demonstrate that TLR5 signaling positively regulates liver regeneration and suggest the potential of TLR5 agonist to promote liver regeneration.